ELLIE FONG: Open Payments
NPI 1831251990 · SEAL BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,622 in 59 payments from 16 companies in 2025. Trend: 2023 $810 · 2024 $1,635 · 2025 $1,622
Food & beverage: $1,622
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 3 | $320 |
| Insulet Corporation | 6 | $197 |
| Abbott Laboratories | 8 | $168 |
| Tandem Diabetes Care, Inc. | 5 | $158 |
| Lilly USA, LLC | 9 | $152 |
| Janssen Biotech, Inc. | 5 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $92 |
| BETA BIONICS, INC. | 3 | $75 |
| Amgen Inc. | 3 | $63 |
| Novo Nordisk Inc | 3 | $59 |
Products named: Korlym, Omnipod, FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, JARDIANCE, TREMFYA, iLet Bionic Pancreas.
Industry payments across CA — which companies pay providers there.
